Evidence map›Paper›PMID 33192552›Full record

SynthesisFrontiers in physiology2020

Trends in Glucocerebrosides Research: A Systematic Review.

Mazarine Desplanque, Marie-Amandine Bonte, Bernard Gressier, David Devos, Marie-Christine Chartier-Harlin, Karim Belarbi

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mazarine DesplanqueUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
Marie-Amandine BonteUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
Bernard GressierUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
David DevosUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
Marie-Christine Chartier-HarlinUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
Karim BelarbiUniv. Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, Lille, France.
Lille Neurosciences & CognitionInserm · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucocerebrosides are sphingolipid components of cell membranes that intervene in numerous cell biological processes and signaling pathways and that deregulation is implicated in human diseases such as Gaucher disease and Parkinson's disease. In the present study, we conducted a systematic review using document co-citation analysis, clustering and visualization tools to explore the trends and knowledge structure of glucocerebrosides research as indexed in the Science Citation Index Expanded database (1956-present). A co-citation network of 5,324 publications related to glucocerebrosides was constructed. The analysis of emerging categories and keywords suggested a growth of research related to neurosciences over the last decade. We identified ten major areas of research (e.g., clusters) that developed over time, from the oldest (i.e., on

Indexed as

cancer drug resistancegangliosidesgaucher diseaseglucocerebrosidesglucosylceramideslipidsParkinson Diseasesphingolipids

Identifiers

PMID33192552
PMCPMC7658098
OpenAlexW3094954939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.